Immunoprecise Antibodies Ltd
Officers & Directors
Dr. Jennifer L. Bath has served as CEO, President, and Director of ImmunoPrecise Antibodies Ltd. since February 2018. She holds a Ph.D. in Cellular and Molecular Biology with a focus on immunology and biochemistry, has been a tenured Associate Professor, founded the Concordia Global Vaccine Institute, and has executive experience at Aldevron, LLC. Dirk Witters has been Chair of the Board and Director since September 2023. He founded Conanti Consult BV in 2019, advised New Rhein Healthcare Investors, served as Director of the Program Management Office at KBC Group, and was president of BioStrand BV. Kamil Isaev has been a Director since February 2025, bringing over 30 years of experience in AI and semiconductor technologies, with leadership roles at Intel, Dell EMC, Align Technology, and ABRT VC, where he is a Venture Partner leading AI initiatives. Joseph Scheffler has been Interim CFO since February 2025. Dr. Ilse Roodink has been Chief Scientific Officer since July 2021. Kari Graber has been Vice President of Commercial Services since November 2021.
Immunoprecise Antibodies Ltd currently has 1278 employees.
News about Immunoprecise Antibodies Ltd Key Personnel |
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is excited to announce significant changes within its Board of Directors and the anticipated release of its second-quarter 2024 earnings report. With a strong focus on AI-driven biotherapeutic research and technology, ImmunoPrecise continues to pave the way for innovative advancements in the field.
At ImmunoPrecise s recent Annual General Meeting, Mitch Levine joined the company s Board of Directors and was subsequently appointed as Chairman of the Board. Levine s exceptional expertise and wealth of experience add tremendous value to the company s strategic decision-making process and overall governance. With this key appointment, ImmunoPrecise aims t...
|
|
